Abraham Freilich
Brooklyn, NYNPI 1730180795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 35.3% of the total. Reporting peaked in 2019 at $904 and has fallen 94.0% since, to $54 in 2023.
Across 169 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$928
- Sun Pharmaceutical Industries Inc.$355
- Novartis$233
- AbbVie$202
- Pfizer$178
- Regeneron Healthcare Solutions, Inc.$168
- plus $565 from 13 others
What the payments were for
- Food & beverage$2,43292%
- Education$1988%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 62 | $928 |
| Sun Pharmaceutical Industries Inc. | 24 | $355 |
| Novartis | 16 | $233 |
| AbbVie | 18 | $202 |
| Pfizer | 11 | $178 |
| Regeneron Healthcare Solutions, Inc. | 4 | $168 |
| Sanofi | 7 | $161 |
| Incyte Corporation | 5 | $77 |
| Lilly USA, LLC | 5 | $73 |
| Mayne Pharma Commercial LLC | 5 | $70 |
| Biofrontera Inc. | 2 | $38 |
| Galderma Laboratories, L.p. | 2 | $33 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $32 |
| Bristol Myers Squibb | 1 | $16 |
| Taro Pharmaceuticals USA, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $15 |
| Aclaris Therapeutics, Inc. | 1 | $12 |
| Almirall LLC | 1 | $12 |
| Dermira, Inc. | 1 | $12 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 14 | $461 |
| Hydrocortisone | 17 | $76 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.